A Multi-site Randomised Controlled Trial Comparing The Severity Of Constipation Symptoms Experienced By Palliative Care Patients Receiving Usual Care Compared To Those Diagnosed And Managed According To The Underlying Pathophysiology.
Funder
National Health and Medical Research Council
Funding Amount
$498,795.00
Summary
This research aims to consider whether the problems of constipation in palliative care are less severe when the physical changes that underlie the problem are explored.
Mechanisms Of Ataxia In Spinocerebellar Ataxia Type 1 Transgenic Mice
Funder
National Health and Medical Research Council
Funding Amount
$361,158.00
Summary
Degeneration of the coordination part of the brain (cerebellum) causes ATAXIA. There are many types, but few can be cured. The majority, affecting ~ 3,000 Australians, are progressive, and can only be helped by physical therapies. We are searching for a drug to improve the SYMPTOMS of ataxia, by analysing the chemical transmitters in the cerebellum in genetically ataxic mice. If we find an imbalance, we will trial appropriate drugs to try to correct this and lessen ataxia.
Australian Centre For Cannabinoid Clinical And Research Excellence (ACRE): Quality And Safety In The Implementation Of Medicinal Cannabis Use In The Community
Funder
National Health and Medical Research Council
Funding Amount
$2,498,471.00
Summary
Australia has a world-first opportunity to develop rigorous medical cannabis research based on quality clinical and environmental science that tests and selects cannabis constituents affecting health and sickness. It will be able to design and coordinate dose and formulation-finding studies to assess safety and efficacy of different cannabinoids. This information will enable registration of products for health that have been thoroughly researched and tested to levels acceptable for public use.
A Sequential Multiple Assignment Randomised Trial (SMART) Of Nursing Interventions To Reduce Pain Associated With Chemotherapy Induced Peripheral Neuropathy
Funder
National Health and Medical Research Council
Funding Amount
$713,418.00
Summary
Modern chemotherapy treatments can result in damage to the peripheral nerves, resulting in a condition called peripheral neuropathy. This condition is characterised by a range of sensory and functional changes that can cause pain and reduced ability to perform daily activities. This project will test various non-pharmacological pain management measures to determine if they are effective in improving the quality of life of patients who experience this problem.
Development And Evaluation Of A Tailored Fatigue Self-management Behavioural Intervention For Patients With Advanced Cancer
Funder
National Health and Medical Research Council
Funding Amount
$157,836.00
Summary
Fatigue (tiredness and exhaustion) is one of the most distressing symptoms experienced by 74% of patients with advanced cancer. This research program aims to develop a sustainable intervention for enabling patients to use self-management strategies, thereby reducing the severity and impact of fatigue.
Prospective Study Of Medical Emergency Team Calls To Define Issues Of End Of Life Decision Making
Funder
National Health and Medical Research Council
Funding Amount
$48,700.00
Summary
A Medical Emergency Team (MET) is a specialised team of doctors and nurses from the Intensive Care Unit who urgently come to patients on the general wards whose medical condition is very unstable. They have to make crucial decisions about their treatment in a very short time. The previous research in this area has been focussed on improving medical outcomes, however it is also apparent that the patients having MET calls are often seriously ill with life limiting illnesses. This study aims to exp ....A Medical Emergency Team (MET) is a specialised team of doctors and nurses from the Intensive Care Unit who urgently come to patients on the general wards whose medical condition is very unstable. They have to make crucial decisions about their treatment in a very short time. The previous research in this area has been focussed on improving medical outcomes, however it is also apparent that the patients having MET calls are often seriously ill with life limiting illnesses. This study aims to explore the broader aspects of care at this time, which are of paramount importance to patients and their families, such as various aspects of communication, particularly focusing on changing goals of care; and also the symptoms that may be causing significant distress for the patient. This project will provide information that will assist development of interventions that will both aim to improve quality of life and also communication in the setting of medical emergencies in patients with life limiting illness.Read moreRead less
Cellular Modelling Of Attention Deficit Hyperactivity Disorder (ADHD) Risk Genes
Funder
National Health and Medical Research Council
Funding Amount
$753,746.00
Summary
Attention deficit hyperactivity disorder is a prevalent behavioural disorder affecting 7.4% of Australian children and adolescents. It has a strong genetic component with high heritability estimates (75–90%) comparable to other serious mental illness such as autism and schizophrenia. Identification and functional characterization of the genetic causes of this disorder will enhance our knowledge of its neurobiology and revolutionise the drug treatment of the disorder.
Use Of Oral Enzymes To Treat Carbohydrate Intolerance: Adjunct Therapy To The Low FODMAP Dietary Treatment Of Irritable Bowel Syndrome.
Funder
National Health and Medical Research Council
Funding Amount
$610,197.00
Summary
Irritable bowel syndrome (IBS) is a common disorder affecting 1 in 7 Australians and fermentation of poorly digested short chain carbohydrates are major dietary triggers. The lack of certain digestive enzymes is a major reason why some carbohydrates are not digested. This project will explore the potential use of oral enzyme supplements to assist with the digestion of these indigestible carbohydrates with the potential for use as adjunct therapy to treat gut symptoms associated with IBS.
Evaluating Novel Methods For Delivering Non-pharmacological Interventions For Dyspnoea In Cancer Patients
Funder
National Health and Medical Research Council
Funding Amount
$506,036.00
Summary
Dyspnoea, or breathlessness, can be a common and distressing problem for people with lung cancer. This study aims to test the effectiveness of a patient education program which includes breathing exercises and psychosocial support for helping patients with lung cancer to control their dyspnoea. The education program is novel in that it applies best available evidence about methods for providing information and support for people with cancer to enhance the effectiveness of the intervention. The s ....Dyspnoea, or breathlessness, can be a common and distressing problem for people with lung cancer. This study aims to test the effectiveness of a patient education program which includes breathing exercises and psychosocial support for helping patients with lung cancer to control their dyspnoea. The education program is novel in that it applies best available evidence about methods for providing information and support for people with cancer to enhance the effectiveness of the intervention. The study will test whether the intervention reduces a patients' feelings of breathlessness, improves their ability to function, and minimises their emotional distress. The intervention being evaluated in this study has been developed so that it can be readily incorporated into routine clinical practice. The study will also examine the effectiveness of this intervention over time, to identify which patients may benefit from this approach and at what times the intervention may be of most use. The information gained from this study will provide more specific guidance to practitioners for targeting intervention approaches to each individual patient's needs.Read moreRead less
A Double-blind Randomised Controlled Multi-site Study Of Sertraline Compared With Placebo For Refractory Breathlessness
Funder
National Health and Medical Research Council
Funding Amount
$603,517.00
Summary
People with optimally treated emphysema often have breathlessness at rest or with little effort (dressing, preparing a meal). No medications are registered to reduce this breathlessness. This 3 year project will study whether a commonly used anti-depressant, sertraline, can reduce this breathlessness even if people are not depressed. Across Australia, 150 people will take part for at least 4 weeks to rate the unpleasantness of their breathlessness on sertraline or an identical sugar tablet.